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Abstract: Potential utilization of proteins for early detection and diagnosis of various 
diseases has drawn considerable interest in the development of protein-based multiplex 
detection techniques. Among the various techniques for high-throughput protein screening, 
optically-encoded beads combined with fluorescence-based target monitoring have great 
advantages over the planar array-based multiplexing assays. This review discusses recent 
developments of analytical methods of screening protein molecules on microbead-based 
platforms. These include various strategies such as barcoded microbeads, molecular 
beacon-based techniques, and surface-enhanced Raman scattering-based techniques.  
Their applications for label-free protein detection are also addressed. Especially, the  
optically-encoded beads such as multilayer fluorescence beads and SERS-encoded beads 
are successful for generating a large number of coding. 
Keywords: optically-encoded bead; fluorescence; quantum dots; surface-enhanced Raman 
scattering (SERS); bead-based assay; label-free detection; high-throughput screening 
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High-throughput screening (HTS) of biomarkers has great potential for clinical and genetic analysis, 
and medical diagnostics. Because proteins can indicate the state of disease progression and the 
functions of normal biological processes within the human body, HTS techniques that identify proteins 
and their expression levels are very important for early detection, diagnosis, and therapy [1–7]. 
The most widely used method for protein analysis in basic research and clinical diagnostics is the 
enzyme-linked immunosorbent assay (ELISA) [8–10]. Mass spectrometry also plays a major role in 
protein analysis [11–14]. However, because these assay methods can only be used to analyze one or a 
few samples at a time, they are not suitable for high-throughput assays with reduced assay volumes [15,16]. 
Planar microarrays (protein chips) and bead-based microarrays (suspension arrays) are widely used 
to date for multiplex protein detection. The microarray chip-based screening has many advantages over 
ELISA such as assay miniaturization, multiplexing, low consumption of samples (less than a nanoliter), 
and high-throughput screening [17–20]. Thus, this method is now becoming one of the most powerful 
tools for multiplexed protein analysis. However, proteins can be expressed in a wide range (~106 fold), 
and hence a large dynamic range of detection level is recommended for protein detection. In this 
regard, small sample volume on microarray spots may reduce the dynamic range of detection in some 
cases [21–23]. 
As one of widely used methods for the multiplex detection of biomolecules, bar-coded (encoded) 
micro-sized beads (microbeads) have been used in bead-based arrays (suspension or liquid arrays) [22,24,25]. 
These techniques have several advantages over the chip-based substrates in development of HTS 
systems for protein detection [15,26–29]: (1) beads can have larger surface areas than planar chips as 
illustrated by LuminexTM claiming ~106 capture molecules per bead. This means that more capture 
biomolecules can be immobilized on the bead, and thus bead-based arrays are more probable to detect 
a wide range of target proteins; (2) detection is faster and sensitivity is equal to or higher than that of 
ELISAs because the interaction between beads and target molecules can be nearly comparable with 
solution-phase kinetics; (3) target molecules can be collected by using flow cytometry such as 
fluorescence-activated cell sorting (FACS); (4) Large-scale fabrication and surface modification is 
possible, and the prepared beads can be stored. Thus, customization is possible by selective mixing of 
antibody-conjugated microbeads; (5) beads can be used with combination of microfluidic devices to 
detect trace amounts of molecules in a manner of automation.  
In the microbead system, capture molecules that specifically bind to target analytes are immobilized 
to corresponding unique bar-coded micro-sized beads. By decoding the beads, the identity of captured 
analytes can be determined. Thus, the system needs two readouts as shown in Figure 1: (1) the  
bar-coded micro-sized beads for multiplexing; (2) the target binding events on each particle [30]. 
Until now, a number of encoding strategies such as chemical encoding, electronic encoding, 
graphical encoding and spectrometric encoding have been proposed and demonstrated [30–32]. 
Among various methods, optically encoded beads have been widely used with well developed optical 
readout tools [33–35], since decoding of optically encoded beads is non-invasive, and coding is stable 
in surface modification and protein binding [1,36–38]. 
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Figure 1. Schematic illustration of principle of a bead based assay. 
 
There are various approaches for coding and decoding of beads, and for identification of the 
binding event of a protein with a capture molecule on beads. Fluorescence-based detection has been 
widely used to detect binding event owing to several major advantages: easy visualization, 
quantification of target molecules, selective excitation of fluorophores (for example, fluorescein 
isothiocyanate (FITC), rhodamine isothiocyanate (RITC), Cy series dyes or Alexa Fluor dyes) and fast 
readout [39,40]. 
Recently, our group has introduced several kinds of optically-encoded bead and together with 
strategies for protein binding event to solve some of the biggest challenges with bead-based arrays 
such as generating a large number of coding and label-free protein detection. This review is focused  
on fluorescence-based multiplex detection systems of proteins with particular emphasis on optically-
encoded beads. 
2. Fluorescence-Encoded Beads for Protein Detection 
2.1. Fluorescence-Encoded Beads 
Among the optical encoding methods, fluorescence-encoding has been most widely used in biological 
applications owing to the simple encoding process, easy detection of large-scale samples, and compatibility 
with a variety of biological chemistries [28,36,41]. The fluorescence-encoded beads are prepared by 
entrapping fluorescent dyes into microbeads composed of, for example, polystyrene. Microbeads can 
have various kinds of encoding by changing different dyes and controlling their concentrations. 
The commercially available Luminex protein detection system is a representative example of 
fluorescence-encoded bead-based assays [22,42]. In the Luminex 100/200 system, polystyrene-based 
microbeads of 5.6-µm size (xMAP microspheres) are used as carriers and stained with precise 
proportions of red and orange fluorophores which denote the bead identity. The red or orange 
fluorophores in the microbeads are measured by photoexcitation with a red-colored laser light for 
decoding the identity of the target. The green dye on the microbeads is measured by photoexcitation 
with a green-colored laser light for quantification of the target protein. The green fluorescence 
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intensity reflects the amount of targets since the fluorescence comes from the secondary probes added 
after target capture to form sandwich immunoassayor hybridization like ELISA. Moreover, the beads 
can be separated by both their optical properties and target amounts by combining with FACS. A new 
system (FLEXMAP 3D by Luminex) using three colors has been introduced to the market allowing to 
multiplex up to a degree of 500 identities. 
Many researchers and several companies have developed microbead-based assay systems based on 
the Luminex system [1]. Very recently, non-commercial activities by the Lund-Johansen group 
resulted in a multiplex of 1725 beads. They combined SEC (size exclusion chromatography) to MAP 
(microsphere-based affinity proteomics) for measuring of large numbers of proteins simultaneously [43]. 
However, broad and overlapping feature of emission bands, complex optical system requiring multiple 
excitation lines, and the limit of practically available dyes hinder broad utilization of this method [32,44]. 
Several emission-based beads were developed to overcome these problems. One is quantum dot  
(QD)-embedded particles [45–50]. QDs, which are colloidal II–VI semiconductor nanocrystals with 
tunable fluorescence emission depending on their size, can overcome many problems of organic 
fluorescence-based beads. Their advantages include excitation in a broad range, narrow (20–30 nm) 
emission spectrum, photostability, high quantum yield of luminescence (20 times brighter), and good 
chemical stability. A large number of codings can be created by embedding QDs of different color into 
beads at precisely-controlled ratios of composition [45]. Theoretically, 10,000–40,000 different types 
of coding beads can be created by using several QD colors and six intensity levels. So far, various 
techniques for embedding QDs into microspheres have been reported and the prepared QD-embedded 
beads were used for multiplex assays [46,48,49]. Thus, QD-encoded beads have great potential to 
become one of the widely used types of optically-encoded beads. 
The other approach to overcome the limited number of fluorescence-encoded beads is the use of 
localized fluorescence-encoded beads. One of the examples is fluorescence dye-doped NP-embedded 
bead [27,51–54] and the microparticles with dyes incorporated layer by layer. Although these 
approaches cannot beat QD-embedded beads in coding capacity, localization of fluorescence can 
increase the encoding capacity and has potential advantages over QD-based ones since fabrication and 
application of QDs can be limited several practical problem such as price of QDs, difficulty of a large 
quantity production, toxicity and hydrophobic properties. 
Recently, our group has developed and used layer-by-layer (multilayer) fluorescence-encoded beads 
for protein detection as illustrated in Figure 2 [35]. This system is produced by using several 
fluorescent dyes such as FITC and rhodamine through diffusion control of an Fmoc-protecting group 
into TentaGel resins. To control the diffusion rate of the Fmoc-protecting group, TentaGel amino resin 
is swollen in an aqueous HCl solution, and then Fmoc-OSu in organic solvent is added to protect some 
parts of the amino groups from the shell surface. Then, the rest of the amino groups are encoded with 
FITC or rhodamine. With repetitions of this process, 10 types of multi-layered fluorescence can be 
prepared with only two dyes. Biotin and a RNA-aptamer, which specifically recognize streptavidin and 
HCV helicase, respectively, are introduced to the multilayer fluorescence-encoded beads and 
monitored for their binding activities to the target molecules. GST-FITC target proteins are selectively 
bound to GST antibody-immobilized beads in a mixture of various ligand-immobilized beads. After 
binding of target (streptavidin-FITC, HCV helicase-Cy3, GST-FITC), the ligands are easily identified 
by their color codes. 
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Figure 2. Fluorescence images of layer-by-layer fluorescence dye particles (reproduced 
with permission from reference [35]. Copyright 2010, Elsevier B.V.). 
 
2.2. Label-Free Protein Detection Using Optically-Encoded Beads 
In order to apply the bead-encoding system to bio-detections, an additional labeling step is generally 
required to monitor protein-binding event. Moreover, the number of matched-pair antibodies in 
sandwich immunoassays is limited for multiplex detection. 
Direct labeling method which is conjugating of fluorophores (e.g., Cy-3, Cy-5) to target can be used 
(Figure 3a). However, several key disadvantages such as generally lower signal intensity and flexibility, 
higher cost, complex labeling procedure limit their usefulness of direct labeling method [55,56]. 
Figure 3. Schematic diagram of two types of the target binding recognition. (a) labeling 
method; (b) label free method.  
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Label-free techniques that monitors inherent property changes of the capture molecule by target 
binding can be used to avoid the above-mentioned problems, and many research groups are currently 
developing label-free planar chip assays based on various tools such as surface plasmon resonance 
(SPR), carbon nanotubes (CNTs), nanowires, nanohole arrays and interferometry [41,57]. The 
combination of label-free protein detection with beads within fluidic platform has been reported.  
Zhao et al. have introduced label-free analyses on inverse-opaline photonic beads [58]. In their system, 
target amount can be used for detection in monitoring the reflection-peak shift. This system has the 
potential to be combined with a microfluidic system. Our group has studied label-free protein detection 
using dielectrophoresis (DEP) force using a microfluidic system. Although this DEP-based approach 
for bead separation by target binding has potential, the current sensitivity is not enough for use in 
protein detection [59]. 
Recently, we combined aptamer-based molecular beacons (MBs) [37] or polydiacetylene (PDA) [60] 
with optically-beads, which can be used with a bead-based array system. The system is designed to 
generate fluorescence by binding event as shown in Figure 3b, and offers the additional advantage of 
separation by target protein amount using flow cytometry. 
Using a sandwich immunoassay format, up to a maximum of 30 targets can be analyzed in 
multiplex within the same sample, which is circumvented by the other method such as direct labeling 
method or label-free detection.  
2.2.1. Molecular Beacon-Based Protein Detection Methods 
MBs have a hairpin structure that can undergo spontaneous conformational changes upon 
hybridization to complementary nucleic acids or protein targets, activating fluorescence resonance 
energy transfer (FRET) [61,62]. For example, the dye molecule does not emit lights when it is near a 
quencher, and it emits when it is distant from quencher. 
MBs are attached to beads by electrostatic or biotin-streptavidin interactions to detect unlabeled 
nucleic acids in solution for multiplex detection [63]. Using beads of different sizes and MBs in two 
fluorophore colors, synthetic nucleic acid sequences were successfully recognized for three respiratory 
pathogens, including the SARS coronavirus in proof-of-concept experiments. Considering that routine 
flow cytometry can detect only up to four fluorescent channels, this assay approach may allow 
multiplex detection of nucleic acids in a single tube. However, there are several obstacles to overcome: 
For example, unstable interactions, random attachment of MBs, and the bulkiness of streptavidin. 
As a different approach, MBs were directly coupled to multilayer fluorescence-encoded beads by 
covalent bonding [37]. In this study, a RNA aptamer was used for thrombin detection and the MB was 
designed as a hairpin structure. One side of the RNA aptamer had a conjugated with a fluorescent dye, 
and the other side was immobilized to the beads containing quencher. By immobilization of these 
“apta-beacons” onto optically-encoded beads, core-shell type beads contain a fluorescent dye-encoded 
core and apta-beacon-coupled shell. In a model study, thrombin (100 nmol) was directly detected using 
this apta-beacon bead method. As illustrated in Figure 4, the fluorophore of the MB would be 
separated from the quencher to allow fluorescence emission (488 nm) when the MBs on the beads bind 
thrombin. Before thrombin treatment, the beads showed only red color (543 nm) from the rhodamine 
encoded at the core layer. The thrombin-bound apta-beacon beads were easily recognized by the 
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appearance of fluorescence without any further labeling step. However, only several RNA aptamers 
have been reported for protein targeting. Because the known RNA aptamer sequence for targeting 
protein can be used for this method, applicable proteins can be highly limited in current stage. 
Figure 4. Schematic illustration of MBs on optically-encoded beads for detecting thrombin 
without additional labeling. (a) before thrombin addition; (b) after thrombin addition [37].  
 
2.2.2. Polydiacetylene-Coated Coding Beads 
PDA-based biosensors have attracted considerable attention due to their unique color change from 
blue to red in response to a variety of stimuli such as applied stress, changes in temperature or pH, and 
ligand-receptor binding. Thus, PDA-based biosensors have been applied to a wide range of analytes, 
including proteins, viruses, antibacterial peptides, antibodies, and pharmacologically active compounds. 
Most PDA-based biosensors are prepared in the form of free-floating vesicles of 100–200 nm or 
planar chips [64–66]. PDA-based biosensors can be combined with fluorescence-encoded materials for 
multiplex detection [60]. In order to combine the PDA to optically-encoded beads, core–shell type 
beads having an optically-coded core are prepared by adapting the preparation method of multilayer 
fluorescence-encoded beads. PDA is then coated onto the optically-encoded beads in a manner similar 
to the chip-based immobilization method, in which monomers are immobilized onto the substrate and 
then PDA is further coated onto it. The prepared PDA-coated beads provide encoding capability as 
well as the PDA sensing of a fluorescence signal and color change induced by external stress (Figure 5). 
Moreover several ligands and their immobilization methods, such as PDA monomer with biotin or 
alkyne group for click reactions [67], have been reported for PDA functionalization. However, because 
PDA property can be changed not only by antibody-antigen binding but also by the other stresses such 
as pH, and temperature, practical applications for high-throughput screening of target proteins can be 
sometimes limited. 
Although these studies are at an early stage, the combination of optically-encoded beads with 
fluorescence-based methods could evolve as a powerful label-free detection method in such fields as 
separation using direct detection of ligand-target binding events, flow cytometry, multiplexing ability, 
and easy and real-time recognition of ligand type and binding event by using CLSM. 
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Figure 5. PDA-coated encoded beads. Illustration of PDA-coated encoded beads of before 
and after stress (upper panel), CLSM images of PDA–FITC encoded beads (lower panel) 
(a–c) unstressed beads and (d–f) stressed beads. (a,d) at a wavelength of 488 nm; (b,e) 
beads at a wavelength of 543 nm; (c,f) at wavelengths of 488 and 543 nm (reproduced with 
permission from reference [60]. Copyright 2011, Elsevier B.V.). 
 
 
3. SERS-Encoded Beads for Protein Detection 
Nanostructures of noble metal such as gold and silver exhibit an optical phenomenon known as 
surface-enhanced Raman scattering (SERS), which enhances Raman scattering of molecules adsorbed 
thereon. When SERS is used as a coding method, it has advantages for bioassays over other optical 
tools: (1) A large number of different Raman signatures can be obtained using different reporter 
molecules. Since SERS peaks are narrow (less than 0.5 nm), spectral overlap is minimized, and thus a 
large number of coding can be created by the combination of chemicals; (2) Choice of photoexcitation 
line is very flexible covering UV to NIR region; (3) There is no photobleaching in Raman scattering; 
(4) They can afford non-invasive analysis of biomolecules and thus are applicable to high-throughput 
screening of various biomolecules [68–72]. 
So far, a large number of SERS-coded materials and readout techniques have been reported [73–79]. 
Because mono-disperse size and homogeneous surface morphology of coding materials are important 
in suspension-array technology for comparison of protein loading levels, monodisperse-sized beads 
with SERS-codes have been manufactured for multiplex protein detection [34,38]. 
Monodisperse micro-sized polystyrene beads prepared by seed polymerization were used as stable 
templates for SERS encoding by our group. Silver NPs were embedded on sulfonated micro-beads 
polystyrene (PS) beads and then Raman-labeled organic compounds were adsorbed on the silver NPs. 
Then, the beads were coated with a silica shell using tetraethoxyorthosilicate (TEOS) for easy surface 
modification and chemical stability. The SERS-encoded beads had uniform size and produced highly 
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intense and reproducible Raman signatures. Moreover, the size of PS beads could be controlled by 
changing backbone size, and additional function such as magnetic property can be incorporated to the 
SERS-encoded beads. The protein p53 which is tumor suppressor protein was chosen as a model to 
show that the SERS-encoded beads could be used for protein detection. By using p53 antibody-conjugated 
SERS-encoded beads, the p53 tumor suppressor protein in a protein mixture was successfully detected 
by sandwich-type bioassays. 
The key advantage of this system comes from combination of flow cytometry with optically-encoded 
beads [45,80]. SERS-encoded beads were applied to conventional fluorescence based flow cytometry 
to separate target protein bounded beads [34]. In this study, fluorescence-immobilized streptavidin was 
selectively bound to biotin-immobilized SERS beads among the various ligand-immobilized beads. 
Then, the target protein-bound beads, which have relatively bright fluorescence, could be separated 
from the others using flow cytometry, and then the ligands could be recognized by SERS decoding of 
the beads as shown in Figure 6. The Nolan group has reported SERS-based flow cytometry separation 
by SERS spectra [81]. They have successfully distinguished four different SERS-encoded beads.  
Figure 6. Illustration of applying fluorescence-based protein detection with SERS 
encoding for HTS system. Fluorescence active streptavidin bound beads were separated 
using flow cytometry, and analyzed by Raman spectroscopy for recognition of Raman labels 
and ligand types. (BT: benzenethiol, 4-MT: 4-mercaptotoluene, 2-NT: 2-naphthalenethiol, 
4-ATP: 4-aminothiophenol) (reproduced with permission from reference [34]. Copyright 
2009, Elsevier B.V.). 
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To take the advantage of the combination of fluorescence-based immunoassays with  
optically-encoded beads, the choice of fluorescent dye requires special considerations for avoiding 
spectral overlap. Because fluorescent dyes have narrow excitation wavelengths, they can be selectively 
excited by laser sources and spectral emission overlap can be avoided. When combining QD-encoded 
beads and fluorescence-based detection, the overlap can be generally avoided by using emitting spectra, 
although QDs can be excited by broad wavelengths. Because fluorescence-based coding is based on 
different emitting wavelengths, combination of fluorescence-based immunoassays with optically-encoded 
beads could limit coding numbers, and consequently multiplexing ability. 
One of main advantages of combining fluorescence-based protein detection with SERS-encoded 
beads is that the target binding event and the type of ligand can be simultaneously recognized by 
fluorescence and SERS, respectively, with single laser-line excitation and without interference by 
coding number. 
Fluorescence is quenched by the interaction between metal surfaces and fluorescent dye molecules, 
and thus, fluorescent dyes are widely used as Raman label compounds to produce resonance Raman 
signals. However, in the case of using fluorescence and SERS together, fluorescence part is physically 
separated from silver NPs as SERS substrate, and this prevents quenching of fluorescence. 
Another point to be considered is that fluorescence can overlap the SERS spectrum. The best 
approach is to avoid overlap. For example, when we used FITC (530 nm) or Cy5.5 (670 nm) as 
fluorescent dyes for target detection in the case of silver-based SERS coding (514-nm laser source), 
the FITC spectra covered the SERS signal but the Cy5.5 spectra did not, as shown in Figure 7a,b. Thus, 
the Cy5.5 band at 670 nm did not overlap with Raman signals, and the SERS spectra of 4-BT could be 
easily recognized, denoting the ligand type, without severe interference from fluorescence background.  
Figure 7. Fluorescence change after photoexcitation by a 514.5-nm laser line on SERS 
beads incubated with streptavidin-FITC conjugate (a) and with streptavidin-Cy5 conjugate 
(b). The corresponding SERS spectrum of (a) is drawn in (c) (Reproduced with permission 
from references 34 and 38. Copyright 2009, Elsevier B.V. and Copyright 2007, American 
Chemical Society, respectively.). 
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On the other hand, in SERS decoding of fluorescence with SERS beads, broad fluorescence 
background of FITC at 530 nm almost covered the SERS peaks. This overlap could be avoided by 
fluorescence photobleaching. Because SERS peaks are not photobleachable, only the intensity of 
fluorescence was gradually decreased by laser illumination. After about 100 s, fluorescence was 
almost completely photobleached, and the 4-MT SERS peaks were obtained as shown in Figure 7c. 
When PDA-based label-free detection methods were applied to SERS-encoded beads, the red  
PDA-immobilized SERS bioassay is combined with a SERS-encoded bead system, multiplexing of a 
large number of targets can be accomplished. Moreover, detection of target binding and decoding of 
coded beads can be beads exhibited fluorescence at 543 nm. At this wavelength, SERS signal could be 
detected. This illustrates that PDA-based label-free detection methods can be combined with SERS-
encoded beads. When a fluorescence-based accomplished by using a single laser source. Therefore, 
SERS-coded beads can be one of the best candidate methods for bead-based protein detection, and 
combination of SERS and fluorescence is likely to be useful for multiple protein detection. 
4. Conclusions and Perspectives 
Currently, the analysis of multiple analytes in a single biological sample is required for diagnostic 
applications. These demands can be met by using multiplex platforms such as planar and bead-based 
arrays. Bead-based arrays have many advantages in sensitivity, flexibility, and the requirement of 
small sample volume over planar arrays. In particular, the combination of fluorescence-based detection 
with optically-encoded beads can provide a robust and efficient approach for setting up multiplexed 
assays. In this review, we have briefly summarized recent developments in the area of optically-encoded 
beads based screening of protein molecules. We have also focused on the optically-encoded beads 
such as multilayer fluorescence beads and SERS-encoded beads which have potential to generate a 
large number of coding for multiplexing detection. Combination of several strategies like molecular 
beacon-based techniques or PDA techniques with those beads is also discussed to show the potential 
for label-free protein. 
Even though plenty of success has been, in order for bead-based assays to be more practically 
achieved in this field, several issues still need to be resolved, including a large number of optical codes, 
rapid readout method, safety, cost, sensitivity, and ease of use for bioapplications such as multiple 
protein detection in clinical diagnostics.  
(1) With regard to coding materials, unlimited coding number has not been fully accomplished. 
Fluorescence-based beads can be limited in their number and/or toxicity. Although the coding number 
of SERS beads has great potential in respect of coding numbers, they have not been completely 
established. So far, only several to dozens of Raman dyes are widely used, and different signal 
intensity and signal complexity sometimes limit their practical coding number. 
(2) For detection of protein binding, on-beads label-free detection is still at the beginning stage. 
Development of more smart and practical detection method is necessary to multiplex, fast and 
sensitive detection.  
(3) The great advantages of optically-encoded beads came from well developed decoding and 
sorting system. So far decoding and sorting with flow cytometry seem to give best performance and 
can be immediately applicable and promising way. 
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The combination of fluorescence-based detection and SERS materials could make bead-based 
assays more attractive in the medical and diagnostic fields. We also expect that the recently  
developed fluorescence-based label-free method will significantly contribute to the expanded use of 
bead-based assays. 
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